ID   JBUSH
AC   CVCL_E715
SY   JBush; J BUSH
DR   dbMHC; 48912
DR   ECACC; 88052035
DR   IHW; IHW09035
DR   IPD-IMGT/HLA; 10825
DR   Wikidata; Q54898534
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01:01:01; B*38:01:01; C*12:03:01:01; DPB1*04:01:01; DQA1*05:05; DQB1*03:01:01; DRB1*11:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=10825).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
RX   DOI=10.1007/978-1-4612-3552-1_2;
RA   Yang S.Y., Milford E.L., Hammerling U., Dupont B.;
RT   "Description of the reference panel of B-lymphoblastoid cell lines for
RT   factors of the HLA system: the B-cell line panel designed for the
RT   Tenth International Histocompatibility Workshop.";
RL   (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.11-19; Springer; New York; USA (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_4;
RA   Mickelson E.M., Reinsmoen N.L., Robbins F.-M., Hartzman R.J., Odum N.,
RA   Svejgaard A., Farrell C., Honeyman M.C., Flomenberg N., Sell T.W.,
RA   Eckels D.D.;
RT   "HLA-Dw and HLA-DP typing of the reference panel of B-lymphoblastoid
RT   cell lines.";
RL   (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.38-42; Springer; New York; USA (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_5;
RA   Yang S.Y.;
RT   "Assignment of HLA-A and HLA-B antigens for the reference panel of
RT   B-lymphoblastoid cell lines determined by one-dimensional isoelectric
RT   focusing (lD-IEF) gel electrophoresis.";
RL   (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.43-44; Springer; New York; USA (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_6;
RA   Knowles R.W.;
RT   "Assignment of HLA-class II alpha and beta chain 2-D gel patterns for
RT   the workshop reference panel of B-lymphoblastoid cell lines.";
RL   (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.44-46; Springer; New York; USA (1989).
//
RX   DOI=10.1007/978-1-4612-3552-1_7;
RA   Flomenberg N.;
RT   "Assignment of T-cell-defined (TCD) HLA class II specificities for the
RT   reference panel of B-lymphoblastoid cell lines.";
RL   (In book chapter) Immunobiology of HLA. Volume I. Histocompatibility testing 1987; Dupont B. (eds.); pp.46-48; Springer; New York; USA (1989).
//
RX   PubMed=8813743; DOI=10.1111/j.1399-0039.1996.tb02596.x;
RA   Prasad V.K., Yang S.Y.;
RT   "Allele assignment for HLA-A, -B, and -C genes to the Tenth
RT   International Histocompatibility Workshop cell lines.";
RL   Tissue Antigens 47:538-546(1996).
//
RX   PubMed=28360230; DOI=10.1101/gr.213538.116; PMCID=PMC5411776;
RA   Norman P.J., Norberg S.J., Guethlein L.A., Nemat-Gorgani N., Royce T.,
RA   Wroblewski E.E., Dunn T., Mann T., Alicata C., Hollenbach J.A.,
RA   Chang W.-H., Shults Won M., Gunderson K.L., Abi-Rached L., Ronaghi M.,
RA   Parham P.;
RT   "Sequences of 95 human MHC haplotypes reveal extreme coding variation
RT   in genes other than highly polymorphic HLA class I and II.";
RL   Genome Res. 27:813-823(2017).
//
RX   PubMed=29171935; DOI=10.1111/tan.13184;
RA   Turner T.R., Hayhurst J.D., Hayward D.R., Bultitude W.P., Barker D.J.,
RA   Robinson J., Madrigal J.A., Mayor N.P., Marsh S.G.E.;
RT   "Single molecule real-time DNA sequencing of HLA genes at ultra-high
RT   resolution from 126 international HLA and immunogenetics workshop cell
RT   lines.";
RL   HLA 91:88-101(2018).
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//